Last updated on September 2017

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.


Brief description of study

A phase 2A, randomized, double-blind, placebo-controoled, study to evaluate safety and efficacy of PF-06700841 in subjects with moderate to severe plaque psoriasis.

Detailed Study Description

12 week double-blind study with a 8 week followup.

Clinical Study Identifier: TX152867

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.